Tag: FDA-approved BTC regimen 2024

Home / FDA-approved BTC regimen 2024

Categories

Pembrolizumab with chemotherapy is approved by the USFDA for biliary tract cancer

On October 31, 2023, the Food and Drug Administration approved pembrolizumab (Keytruda, Merck) to be used with gemcitabine and cisplatin to treat biliary tract carcinoma (BTC) that has spread or is l...
fda-approved-btc-regimen-2024

Scan the code